Review
Open access
Jul 2026
Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2– Advanced Breast Cancer
Emerging strategies targeting this pathway to overcome resistance in advanced disease aim to enhance durability of response, minimize toxicity, and improve survival in HR+/HER2- metastatic breast cancer.
L. Lei, M. Canning, E. Sakach et al.
· Drugs · 0 citations